Elizabeth Montes-Servín

Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients

D. Gallardo-Rincón, Elizabeth Hernández-Nava, Alfredo Toledo-Leyva, 2019, Translational oncology.

Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12

D. Gallardo-Rincón, Abraham Pedroza-Torres, L. Cetina-Pérez, 2022, Frontiers in Genetics.

CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients

O. Arrieta, J. Borbolla-Escoboza, L. Barrera, 2017, British Journal of Cancer.